About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

Artificial intelligence is intended to help reduce human labor, but classrooms are for humans to learn through labor. Where ...

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...

HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the Group") is pleased to announce the official signing of a tripartite ...

A new class of engineered extracellular vesicles induces antigen-specific regulatory T cells, offering a targeted strategy for treating autoimmune and allergic diseases.

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...

Biologists have long treated the cell as a chemical factory, but a new wave of research is forcing a rethink of that familiar ...

An international research team identified hundreds of genes essential for the development of brain cells, including one gene ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...